Showing 1 - 6 results of 6 for search 'CNM Breviglieri', 查询时间: 0.03s Refine Results
  1. 1
    BLINATUMOMAB + DONOR LEUKOCYTE INFUSIONS (DLI) CAN BE USED TO PREVENT THE RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT)

    BLINATUMOMAB + DONOR LEUKOCYTE INFUSIONS (DLI) CAN BE USED TO PREVENT THE RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT) 由 CNM Breviglieri, VC Ginani, RG Vasconcelos, CN Santos, ABW Batalha, MRS Oliveira, A Seber

    出版 2024-10-01
    获取全文
    文件
  2. 2
    BRIDGING THE GAP IN POST-TRANSPLANT CARE FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): INNOVATIVE MAINTENANCE STRATEGIES TO REDUCE RELAPSE RATE AND ENHANCE SURVIVAL

    BRIDGING THE GAP IN POST-TRANSPLANT CARE FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): INNOVATIVE MAINTENANCE STRATEGIES TO REDUCE RELAPSE RATE AND ENHANCE SURVIVAL 由 CNM Breviglieri, CN Santos, RG Vasconcelos, VC Ginani, ABW Batalha, MRS Oliveira, GS Alencar, JF Marques, A Seber

    出版 2024-10-01
    获取全文
    文件
  3. 3
    REVOLUTIONIZING POST-TRANSPLANT CARE IN PEDIATRIC ACUTE MYELOID LEUKEMIA (AML) WITH TAILORED MAINTENANCE THERAPIES: A LEAP TOWARDS ENHANCED SURVIVAL AGAINST ACTIVE DISEASE

    REVOLUTIONIZING POST-TRANSPLANT CARE IN PEDIATRIC ACUTE MYELOID LEUKEMIA (AML) WITH TAILORED MAINTENANCE THERAPIES: A LEAP TOWARDS ENHANCED SURVIVAL AGAINST ACTIVE DISEASE 由 CNM Breviglieri, RG Vasconcelos, CN Santos, VC Ginani, MRS Oliveira, ABW Batalha, JF Marques, GS Alencar, A Seber

    出版 2024-10-01
    获取全文
    文件
  4. 4
    ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT) IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): A FEASIBLE CURATIVE OPTION WITH HLA-IDENTICAL OR HAPLOIDENTICAL DONORS

    ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT) IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): A FEASIBLE CURATIVE OPTION WITH HLA-IDENTICAL OR HAPLOIDENTICAL... 由 RV Gouveia, VC Ginani, CNM Breviglieri, G Zamperlini, VADN Varjão, J Marques, CMMSS Parrode, ABW Batalha, EH Goto, A Seber

    出版 2024-10-01
    获取全文
    文件
  5. 5
    A SECOND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT (HCT2) MAY CURE MORE THAN 40% PEDIATRIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

    A SECOND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT (HCT2) MAY CURE MORE THAN 40% PEDIATRIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 由 MF Cardoso, G Zamperlini, CNM Breviglieri, R Gouveia, VC Ginani, JF Marques, LL Quintino, LDS Domingues, MGAD Matos, A Seber

    出版 2023-10-01
    获取全文
    文件
  6. 6
    WHY DO PATIENTS WITH SICKLE CELL ANEMIA REFERRED TO HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT) AND WILLING TO UNDERGO TRANSPLANT MAY NEVER HAVE IT? CAN WE CHANGE THIS REALITY?

    WHY DO PATIENTS WITH SICKLE CELL ANEMIA REFERRED TO HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT) AND WILLING TO UNDERGO TRANSPLANT MAY NEVER HAVE IT? CAN WE CHANGE THIS REALITY? 由 RV Gouveia, LL Quintino, CM Lustosa, ASS Ibanez, MGAD Matos, CMMSS Parrode, VADN Varjão, CNM Breviglieri, VC Ginani, A Seber

    出版 2024-10-01
    获取全文
    文件

检索工具: